Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is one of the leading infectious disease causes of morbidity and mortality worldwide. Though current antibiotic regimens can cure the disease, treatment requires at least six months of drug therapy. One reason for the long duration of ther...
Main Authors: | Mi-Sun Koo, Claudia Manca, Guibin Yang, Paul O'Brien, Nackmoon Sung, Liana Tsenova, Selvakumar Subbian, Dorothy Fallows, George Muller, Sabine Ehrt, Gilla Kaplan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-02-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3045423?pdf=render |
Similar Items
-
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.
by: Selvakumar Subbian, et al.
Published: (2011-09-01) -
Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection.
by: Claudia Manca, et al.
Published: (2013-01-01) -
Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response
by: Selvakumar Subbian, et al.
Published: (2011-01-01) -
Strain specific transcriptional response in <it>Mycobacterium tuberculosis </it>infected macrophages
by: Koo Mi-Sun, et al.
Published: (2012-01-01) -
Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model
by: Ranjeet Kumar, et al.
Published: (2020-01-01)